JP2021527424A5 - - Google Patents

Info

Publication number
JP2021527424A5
JP2021527424A5 JP2020570743A JP2020570743A JP2021527424A5 JP 2021527424 A5 JP2021527424 A5 JP 2021527424A5 JP 2020570743 A JP2020570743 A JP 2020570743A JP 2020570743 A JP2020570743 A JP 2020570743A JP 2021527424 A5 JP2021527424 A5 JP 2021527424A5
Authority
JP
Japan
Prior art keywords
seq
nos
amino acid
group
antibody
Prior art date
Application number
JP2020570743A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019246176A5 (https=
JP2021527424A (ja
JP7634993B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/037865 external-priority patent/WO2019246176A1/en
Publication of JP2021527424A publication Critical patent/JP2021527424A/ja
Publication of JPWO2019246176A5 publication Critical patent/JPWO2019246176A5/ja
Publication of JP2021527424A5 publication Critical patent/JP2021527424A5/ja
Priority to JP2024099610A priority Critical patent/JP2024116399A/ja
Application granted granted Critical
Publication of JP7634993B2 publication Critical patent/JP7634993B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020570743A 2018-06-19 2019-06-19 抗因子ＸＩＩ／ＸＩＩａ抗体およびその使用 Active JP7634993B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024099610A JP2024116399A (ja) 2018-06-19 2024-06-20 抗因子ＸＩＩ／ＸＩＩａ抗体およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862687144P 2018-06-19 2018-06-19
US62/687,144 2018-06-19
PCT/US2019/037865 WO2019246176A1 (en) 2018-06-19 2019-06-19 Anti-factor xii/xiia antibodies and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024099610A Division JP2024116399A (ja) 2018-06-19 2024-06-20 抗因子ＸＩＩ／ＸＩＩａ抗体およびその使用

Publications (4)

Publication Number Publication Date
JP2021527424A JP2021527424A (ja) 2021-10-14
JPWO2019246176A5 JPWO2019246176A5 (https=) 2022-06-20
JP2021527424A5 true JP2021527424A5 (https=) 2022-06-20
JP7634993B2 JP7634993B2 (ja) 2025-02-25

Family

ID=67263076

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020570743A Active JP7634993B2 (ja) 2018-06-19 2019-06-19 抗因子ＸＩＩ／ＸＩＩａ抗体およびその使用
JP2024099610A Pending JP2024116399A (ja) 2018-06-19 2024-06-20 抗因子ＸＩＩ／ＸＩＩａ抗体およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024099610A Pending JP2024116399A (ja) 2018-06-19 2024-06-20 抗因子ＸＩＩ／ＸＩＩａ抗体およびその使用

Country Status (12)

Country Link
US (1) US12068729B2 (https=)
EP (1) EP3810270A1 (https=)
JP (2) JP7634993B2 (https=)
KR (1) KR20210022650A (https=)
CN (1) CN112437682B (https=)
AU (1) AU2019288299B2 (https=)
CA (1) CA3104470A1 (https=)
EA (1) EA202190056A1 (https=)
IL (1) IL279529A (https=)
MA (1) MA52966A (https=)
MX (1) MX2020013894A (https=)
WO (1) WO2019246176A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240352150A2 (en) * 2020-06-16 2024-10-24 Ningbo Comgen Biotech Co., Ltd. Anti-factor xii (fxii) nanobody or antigen-binding fragment thereof, and use thereof
JP2023531315A (ja) * 2020-07-03 2023-07-21 シーエスエル・イノベーション・プロプライエタリー・リミテッド 第ｘｉｉ因子抗原結合タンパク質の高濃度製剤
EP4729546A1 (en) * 2023-06-16 2026-04-22 Jiangsu BioJeTay Biotechnology Co., Ltd. Antibody specifically recognizing factor xiia and use thereof
IL325613A (en) * 2023-07-19 2026-02-01 Regeneron Pharma Antibodies against factor xii/xiia and their uses

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963657A (en) 1988-06-09 1990-10-16 Temple University Of The Commonwealth System Of Higher Education Monoclonal antibodies to the light chain region of human factor XII and methods of preparing and using the same
US5500349A (en) 1989-01-27 1996-03-19 Coagen Limited Blood-coagulation factor XIIA β monoclonal antibody and immunoassay
CA2082643A1 (en) 1990-05-10 1991-11-11 Jan H. Nuijens Inhibitors of factor xii activation and applications thereof
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6891394B1 (en) * 2002-06-04 2005-05-10 Actel Corporation Field-programmable gate array low voltage differential signaling driver utilizing two complimentary output buffers
US7378867B1 (en) * 2002-06-04 2008-05-27 Actel Corporation Field-programmable gate array low voltage differential signaling driver utilizing two complimentary output buffers
US20040101920A1 (en) 2002-11-01 2004-05-27 Czeslaw Radziejewski Modification assisted profiling (MAP) methodology
WO2005103081A2 (en) 2004-04-20 2005-11-03 Genmab A/S Human monoclonal antibodies against cd20
CA2591786C (en) 2004-12-23 2013-07-16 Bernhard Nieswandt Prevention of thrombus formation and/or stabilization
US8257740B1 (en) 2011-08-15 2012-09-04 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
US8246995B2 (en) 2005-05-10 2012-08-21 The Board Of Trustees Of The Leland Stanford Junior University Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
ES2398076T3 (es) 2006-06-02 2013-03-13 Regeneron Pharmaceuticals, Inc. Anticuerpos de alta afinidad contra el receptor de IL-6 humano
US7541838B2 (en) * 2007-03-27 2009-06-02 Intel Corporation Transmitter swing control circuit and method
JP5816170B2 (ja) 2009-06-26 2015-11-18 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体
EP2371857A1 (en) 2010-04-01 2011-10-05 CSL Behring GmbH Factor XII inhibitors for treating interstitial lung disease
EP2384766A1 (en) * 2010-05-03 2011-11-09 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Novel antibody to a carbonic anhydrase
CN103415301A (zh) 2011-03-09 2013-11-27 德国杰特贝林生物制品有限公司 用于与包括与人造表面接触的医疗操作一起施用的fxii抑制剂
EP2497489A1 (en) 2011-03-09 2012-09-12 CSL Behring GmbH Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
BR112014001255B1 (pt) 2011-07-19 2019-07-02 Merck Sharp & Dohme B.V. Composto, uso de um composto, combinação, composição farmacêutica, e, sal farmaceuticamente aceitável de um composto
ES3005912T3 (en) * 2011-07-22 2025-03-17 Csl Behring Gmbh Inhibitory anti-factor xii/xiia monoclonal antibodies and their uses
TWI589299B (zh) * 2011-10-11 2017-07-01 再生元醫藥公司 用於治療類風濕性關節炎之組成物及其使用方法
KR101461652B1 (ko) * 2011-12-16 2014-11-21 주식회사 삼양바이오팜 유착방지용 조성물, 이를 포함하는 유착방지기능을 갖는 수술용 메쉬 복합체 및 이의 제조 방법
EP2623110A1 (en) 2012-01-31 2013-08-07 CSL Behring GmbH Factor XII inhibitors for the treatment of neurological inflammatory disorders
TWI613215B (zh) * 2012-02-22 2018-02-01 再生元醫藥公司 抗－大－內皮素－１（ｂｉｇ－ｅｔ－１）抗體及其用途
WO2014089493A1 (en) * 2012-12-07 2014-06-12 Vanderbilt University Antibodies against factor xii and uses thereof
TWI682941B (zh) 2013-02-01 2020-01-21 美商再生元醫藥公司 含嵌合恆定區之抗體
US9260527B2 (en) * 2013-03-15 2016-02-16 Sdix, Llc Anti-human CXCR4 antibodies and methods of making same
KR20150139089A (ko) * 2014-06-02 2015-12-11 한국전자통신연구원 멀티플라이어 및 다중 입력 증폭기를 포함하는 전류-전압 변환 증폭 회로
US10259874B2 (en) * 2014-10-27 2019-04-16 Agency For Science, Technology And Research Anti-TIM-3 antibodies
CN111919424A (zh) * 2018-07-02 2020-11-10 拉姆伯斯公司 利用早期高阶符号检测用于判决反馈均衡的方法和电路

Similar Documents

Publication Publication Date Title
JP2021527424A5 (https=)
US10577428B2 (en) Anti-factor XI monoclonal antibodies and methods of use thereof
JP7271430B2 (ja) 抗ｘｉ因子抗体
CA2916399C (en) Combination therapy using a factor xii inhibitor and a c1-inhibitor
IL230564B2 (en) Anticoagulant monoclonal antibodies anti–factor xii/fxiia, a method for their preparation, a pharmaceutical compound containing them and medical uses.
CN102027015A (zh) 抗cxcr4抗体
CN114478782B (zh) 抗凝血因子xi抗体
WO2010045518A1 (en) Compositions containing thrombomodulin domains and uses thereof
JP2019529371A5 (https=)
CA3234626A1 (en) Dosing regimens of factor xi/xia antibodies
JPWO2019246176A5 (https=)
AU2016203944A1 (en) Anti-factor xi monoclonal antibodies and methods of use thereof
NO301374B1 (no) Fremgangsmåte for fremstilling av et <alfa>2-antiplasmin monoklonalt antistoff
US11958911B2 (en) Anti-coagulation factor XI antibody
US20090311267A1 (en) Inhibition of VWF - GPIb/V/IX interaction and platelet-collagen interaction for prevention and treatment of cerebral attacks
JP2007508352A5 (https=)
JPWO2022159875A5 (https=)
HK40075244A (en) Anticoagulant factor xi antibodies
HK40057273A (en) Anti-factor xi antibodies
JPWO2020251924A5 (https=)